PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2017.4912019511169-177The Risk of Herpes Zoster in Patients with Non-small Cell Lung Cancer according to Chemotherapy Regimens: Tyrosine Kinase Inhibitors versus Cytotoxic ChemotherapyJi Young Choi, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Seong Jin Johttp://e-crt.org/upload/pdf/crt-2017-491.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2017.491, http://www.e-crt.org/upload/pdf/crt-2017-491.pdf
Clinical Lung Cancer10.3816/clc.2008.n.021200893141-143Monoclonal Antibodies Versus Tyrosine Kinase Inhibitors Concurrent with Chemotherapy in Non–Small-Cell Lung Cancer: Exploring Divergent ResultsPrimo N. Lara, Suresh S. Ramalingamhttps://api.elsevier.com/content/article/PII:S1525730411701486?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730411701486?httpAccept=text/plain
Medical Oncology10.1007/s12032-014-0473-y2015322Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysisLi Sun, Jie-Tao Ma, Shu-Ling Zhang, Hua-Wei Zou, Cheng-Bo Hanhttp://link.springer.com/content/pdf/10.1007/s12032-014-0473-y.pdf, http://link.springer.com/article/10.1007/s12032-014-0473-y/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12032-014-0473-y
Journal of Thoracic Oncology10.1097/01.jto.0000283512.51667.bd200728S509P2-048: Activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in chemotherapy-pretreated non-small cell lung cancer (NSCLC) patients (pts) prospectively selected according to specific molecular predictive factorsCarmen Nuzzohttps://api.elsevier.com/content/article/PII:S1556086415342283?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1556086415342283?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(90)90352-m199061-258Chemotherapy of advanced non-small-cell lung cancer: A randomized trial of three cis-platin-based chemotherapy regimenshttps://api.elsevier.com/content/article/PII:016950029090352M?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029090352M?httpAccept=text/plain
Annals of Oncology10.1016/j.annonc.2020.10.402202031S1402408P Integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring EGFR mutationJ. Maevskaya, K. Laktionov, D. Yudin, L. Vladimirovahttps://api.elsevier.com/content/article/PII:S0923753420428935?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753420428935?httpAccept=text/plain
Radiology and Oncology10.1515/raon-2017-00292017513241-251Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitorsMatjaz Zwitter, Antonio Rossi, Massimo Di Maio, Maja Pohar Perme, Gilberto Lopeshttp://content.sciendo.com/view/journals/raon/51/3/article-p241.xml, https://www.sciendo.com/article/10.1515/raon-2017-0029
Lung Cancer10.1016/s0169-5002(87)80502-019873150Comparison of alternating to nonalternating chemotherapy regimens for non-small cell lung cancerhttps://api.elsevier.com/content/article/PII:S0169500287805020?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500287805020?httpAccept=text/plain
Scientific Reports10.1038/srep36371201661EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutationJianlin Xu, Haitang Yang, Bo Jin, Yuqing Lou, Yanwei Zhang, Xueyan Zhang, Hua Zhong, Huiming Wang, Dan Wu, Baohui Hanhttp://www.nature.com/articles/srep36371.pdf, http://www.nature.com/articles/srep36371, http://www.nature.com/articles/srep36371.pdf
Lung Cancer10.1016/0169-5002(96)84345-51995133350A randomised trial of two cisplatin-containing chemotherapy regimens in patients with Stage III-B and IV non-small cell lung cancerhttps://api.elsevier.com/content/article/PII:0169500296843455?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500296843455?httpAccept=text/plain